EUVIMEDEUVIMED entdecken
Crossref

Treatment results of preoperative concurrent chemoradiotherapy followed by surgery for stage III or IV esophageal squamous cell carcinoma

Hideomi Yamashita, Keiichi Nakagawa, Masao Tago, Naoki Nakamura, Kenshiro Shiraishi, Ken-ichi Mafune, Michio Kaminishi, Kuni Ohtomo

Radiation Medicine · 2006

DOI: 10.1007/bf02489991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Medicine, 2006. Verfasst von Hideomi Yamashita und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Tokyo Hospital, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the treatment outcome of preoperative neoadjuvant radiotherapy combined with chemotherapy (CTx) for 17 esophageal cancer patients. MATERIALS AND METHODS: Between 1992 and 2004, patients with locally advanced esophageal cancer (stage III or IV) before curative-intent surgery received radiotherapy (RT) combined with CTx (Cisplatin: 75 mg/m2, bolus infusion, and 5-fluorouracil (5-FU): 1,000 mg/m2/24 h, continuous infusion for 4 days) at a median total dose of 30 Gy (n=17). RESULTS: The median survival period was 13.8 months. The overall survival rates at 1, 2, and 3 years were 75%, 40%, and 20%, respectively. According to univariate analysis, no factor of worse prognosis was found. Pathological markedly (Grade 3) or moderately (Grade 2) effects were observed in 4 patients (24%) and 8 patients (47%), respectively. CONCLUSION: These results indicate that, although this regimen was effective in terms of pathological effect, it is unclear whether it made a contribution to the improvement of survival

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Squamous CellCisplatinCombined Modality TherapyEsophageal NeoplasmsFemaleFluorouracilHumansMaleMiddle AgedNeoplasm StagingRadiotherapy DosageSurvival RateTreatment Outcome

Substanzen

CisplatinFluorouracil

Autor:innen und Institutionen

  • Department of Radiology, University of Tokyo Hospital, Japan.

Zitieren

APA

Yamashita, H., Nakagawa, K., Tago, M., Nakamura, N., Shiraishi, K., Mafune, K., Kaminishi, M., & Ohtomo, K. (2006). Treatment results of preoperative concurrent chemoradiotherapy followed by surgery for stage III or IV esophageal squamous cell carcinoma. Radiation Medicine. https://doi.org/10.1007/bf02489991

Vancouver

Yamashita H, Nakagawa K, Tago M, Nakamura N, Shiraishi K, Mafune K, et al. Treatment results of preoperative concurrent chemoradiotherapy followed by surgery for stage III or IV esophageal squamous cell carcinoma. Radiation Medicine. 2006. doi:10.1007/bf02489991

BibTeX
@article{Yamashita2006,
  author = {Yamashita, Hideomi and Nakagawa, Keiichi and Tago, Masao and Nakamura, Naoki and Shiraishi, Kenshiro and Mafune, Ken-ichi and Kaminishi, Michio and Ohtomo, Kuni},
  title = {Treatment results of preoperative concurrent chemoradiotherapy followed by surgery for stage III or IV esophageal squamous cell carcinoma},
  journal = {Radiation Medicine},
  year = {2006},
  doi = {10.1007/bf02489991}
}
Kostenlos starten →